Charles Schwab Investment Management Inc. increased its position in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 8.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 290,656 shares of the company's stock after acquiring an additional 22,263 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.72% of Phibro Animal Health worth $6,104,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Rhumbline Advisers raised its stake in Phibro Animal Health by 0.6% during the 4th quarter. Rhumbline Advisers now owns 76,582 shares of the company's stock valued at $1,608,000 after purchasing an additional 484 shares during the last quarter. Los Angeles Capital Management LLC raised its position in shares of Phibro Animal Health by 2.1% during the fourth quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company's stock valued at $505,000 after buying an additional 503 shares during the last quarter. BNP Paribas Financial Markets lifted its stake in shares of Phibro Animal Health by 3.1% in the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company's stock valued at $548,000 after buying an additional 729 shares during the period. New York State Teachers Retirement System grew its position in Phibro Animal Health by 16.7% during the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock worth $114,000 after buying an additional 775 shares in the last quarter. Finally, SG Americas Securities LLC increased its stake in Phibro Animal Health by 7.4% during the fourth quarter. SG Americas Securities LLC now owns 13,162 shares of the company's stock valued at $276,000 after acquiring an additional 906 shares during the period. Institutional investors and hedge funds own 99.34% of the company's stock.
Phibro Animal Health Price Performance
Shares of PAHC traded down $0.22 during trading hours on Friday, hitting $21.46. The stock had a trading volume of 162,158 shares, compared to its average volume of 183,577. The stock has a market capitalization of $869.19 million, a price-to-earnings ratio of 44.71, a P/E/G ratio of 0.45 and a beta of 0.58. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. The company's fifty day moving average is $22.77 and its two-hundred day moving average is $22.65. Phibro Animal Health Co. has a 52 week low of $12.17 and a 52 week high of $26.55.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, analysts anticipate that Phibro Animal Health Co. will post 1.95 EPS for the current year.
Phibro Animal Health Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th were given a dividend of $0.12 per share. The ex-dividend date was Wednesday, March 5th. This represents a $0.48 annualized dividend and a yield of 2.24%. Phibro Animal Health's dividend payout ratio (DPR) is 100.00%.
Wall Street Analysts Forecast Growth
A number of analysts have recently issued reports on PAHC shares. Morgan Stanley boosted their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a research report on Tuesday, December 17th. StockNews.com downgraded shares of Phibro Animal Health from a "buy" rating to a "hold" rating in a report on Tuesday. Finally, Barclays upped their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a research note on Monday, February 10th. Two analysts have rated the stock with a sell rating and three have issued a hold rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $21.00.
View Our Latest Analysis on PAHC
Phibro Animal Health Company Profile
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Featured Articles
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
